← Eichor
Study identifier: NCT06471400 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Trials

Condition: Critical Illness · Loss of Consciousness  ·  Sponsor: University Hospital Freiburg

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersYes

About this study

This study aims to gather insights into the perceptions of legal representatives regarding the recruitment process for clinical trials in the intensive care setting when the patients cannot decide for themselves. With this information, effective strategies will be developed to increase involvement and the feeling of ownership of LARs of (potential) participants in clinical trials and thus enhance and facilitate patient recruitment for clinical trials. The single-arm study design does not include a choice of comparator, as the focus of this trial is to explore the perceptions of the participants at first hand without comparing different cohorts or strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Supady, MD  ·  +4976127034010  ·  alexander.supady@uniklinik-freiburg.de

Always discuss trial participation with your own doctor first.

Locations (1)

Freiburg University Medical CenterFreiburg im Breisgau, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06471400